Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells

Authors: Wittig, Ilka; Groner, Bernd

Source: Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 5, Number 4, December 2005 , pp. 449-463(15)

Publisher: Bentham Science Publishers

Abstract:

STAT5 belongs to a small family of transcription factors with dual functions. The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus. STAT5 regulates the expression of genes, which determine important cellular phenotypes. It can promote proliferation and inhibit apoptosis, but is also involved in the regulation of differentiation between specific gene expression. STAT5 can also contribute to the transformed phenotype. In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells. STAT5 activity appears to be limiting for these phenotypes. Inhibition of STAT5 in these tumor cells results in growth arrest and apoptosis. Targeting of STATs and other downstream mediators of oncogenic tyrosine kinases provides a promising strategy for tumor therapy, which might be refractory to resistance mechanisms incapacitating tyrosine kinase inhibitors. The well-studied steps in the activation of STAT5 and its roles in different subcellular compartments suggest original interference strategies, which could be used to inhibit its function. The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.

Keywords: STAT activation; signal transduction; targeted interference; peptide aptamers; cancer therapy

Document Type: Review article

DOI: http://dx.doi.org/10.2174/156800805774912999

Affiliations: 1: Georg Speyer Haus, Institute for Biomedical Research, Paul Ehrlich Strasse 42, D-60596 Frankfurt am Main, Germany.

Publication date: 2005-12-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Allergy & Immunology ,  Pharmacology
• By this author: Wittig, Ilka ;  Groner, Bernd

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers